As Rob Buttrose and I have argued on the ABC Drum, last year’s update of the Australian code for the care and use of animals for scientific purposes (the Code) has brought no improvement for the animals used in research and teaching. The new Code does not address the lack of transparency and secrecy around the use of animals in research. Many procedures and protocols that are cruel and unnecessary are still allowed, and the new Code provides as little protection to animals as the previous 2004 version.
While the Code encourages the 3Rs: replacement (not using animals where possible), reduction (reducing the number of animals used) and refinement (minimising impact), the number of animals used in research here in Australia and overseas is increasing.
Earlier this year, the UK government launched its delivery plan to replace, refine and reduce the use of animals in research. But, as the BBC reports, there is no commitment to reduce the total number of animal experiments, which has been on the rise.
Change is slow, argue Hartung and Corsini:
Over the last two decades, little has changed in the practice of immunotoxicity testing for regulatory purposes, especially for immunosuppression, and autoimmunity is still a challenge. Current guidelines still rely on animal tests, which include some immune endpoints in repeated dose tests and trigger dedicated tests only when certain alerts indicate a problem. At the same time, however, a wealth of in vitro approaches has been developed, but few have been adopted for routine testing. (p. 411)
So, what are some of the stumbling blocks for change?
Jean Harrington has undertaken research in stem cell laboratories, exploring attitudes toward the use of alternatives, in particular human tissue. She argues that:
The production and maintenance of animal models is a serious commercial concern, deeply woven into the fabric of medical research. Indeed, this leads one to ask whether the artifact—the animal model—has become such an integral part of experimentation that other materials, such as human tissue, are viewed as inappropriate within the scientific framework. (p.188)
For a small lab, the procurement of human tissue is often more difficult and inconvenient than using animals: it requires collaboration with hospitals who supply the tissue (which they consider a waste product). The tissue may arrive at an unsuitable time and require the scientists to work at an inconvenient time, such as over night. The supply of tissue
… is sporadic and the key concepts of control and purity—represented in the manufactured artifact of the manipulated, standardized animal model—are challenged because its heterogeneous nature threatens the replication of the experiments. Thus the use of human tissue places at risk the timely production of publications. These tensions produce an ethical and practical predicament: on one side of the argument, animal models are seen to be the best material to produce what is required— experimentation, results and output; and on the other is the logic of using human tissue to explore human disease. (p. 190)
In the environmental hazard and risk assessment area, Scholz and colleagues have argued that perceptions rather than facts can be stumbling blocks:
Finally, a serious problem in the implementation of alternatives approaches in environmental risk assessments arises from the fact that discussions about alternatives are frequently based upon ‘perceptions’ and not exclusively based on scientific arguments. The problem is that such perceptions may interfere with an objective discussion of pros and cons of various alternative approaches. (p.525)
They conclude that:
Even without available alternative methods, there would be scope for a reduction of animal tests via modification of risk assessment schemes or experimental test designs. (p. 513)
And yet, there have been positive developments.
The cosmetics industry
From June this year, China plans to remove its mandatory animal test requirements for domestically manufactured cosmetic products. This may be expanded to include imported products and certain “special use” cosmetics as well. Europe has already phased out animal tests on cosmetic products and ingredients. Israel and Norway have had bans on animal testing in place for several years and, in 2013, India became the first country in Asia to announce a ban animal testing for cosmetics. Korea, Brazil and ASEAN are also making strides toward ending cosmetics testing on animals.
In the U.S., Congressman Jim Moran has just introduced a Federal Bill to End Cosmetics Testing on Animals in Congress.
The pharmaceutical industry
There are also changes ahead in the pharmaceutical industry. A recent article in the Genetic Engineering & Biotechnology News proclaimed: Alternatives to Animal Testing Drive Market”. The author, Robert G Hunter, commented that in vitro (using tissue and cell cultures) and in silico (performed on a computer) technology
products and services are now about the same size as the in vivo services (contract research organization) industry … In addition to almost doubling the market to $10 billion by 2017, we expect to see increased diffusion of these so-called alternative methods and technologies across clinical applications like biomarkers and systems biology over the next 5–10 years. And mice will play!
Further, the National Institutes of Health in the U.S. announced last year an end to most testing on chimps and support for research that uses chimps.
The world as we have created it is a process of our thinking. It cannot be changed without changing our thinking. ― Albert Einstein
References – some alternatives to animal testing
Doke, S. K., & Dhawale, S. C. (2013). Alternatives to animal testing: A review. Saudi Pharmaceutical Journal
Alt.Tox.org. Non-animal Methods for Toxicity Testing. AltTox.org is a website dedicated to advancing non-animal methods of toxicity testing through online discussion and information exchange.
@ltWeb, the global clearinghouse for information on alternatives to animal testing. Johns Hopkins Bloomberg School of Public Health
Humane Research Australia. Replacing animals
Pincock, S (2013) Miniature kidney grown in a dish. ABC Science
Interview with Alan Faulkner-Jones from Heriot Watt University in Edinburgh (2013). 3D-printed human cells could “replace animal testing”
New England Anti-Vivisection Society (NEAVS). Alternatives In Testing
European Union Reference Laboratory for Alternatives to Animal Testing. Advancing safety assessment without animals: EURL ECVAM. video
Summary of ICCVAM Test Method Evaluations. National Toxicology Program, U.S. Department of Health and Human Services
Antidote Europe. Antidote Europe is a not for profit NGO that promotes sound scientific methods of research and campaigns on issues of consumer safety.